CVS Health (NYSE:CVS) Shares Down 0.6%

CVS Health Co. (NYSE:CVS - Get Free Report)'s share price was down 0.6% during trading on Tuesday . The company traded as low as $56.70 and last traded at $57.05. Approximately 4,645,541 shares traded hands during trading, a decline of 61% from the average daily volume of 11,846,261 shares. The stock had previously closed at $57.40.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. The Goldman Sachs Group dropped their target price on CVS Health from $85.00 to $74.00 and set a "buy" rating on the stock in a research report on Thursday, May 2nd. UBS Group lowered shares of CVS Health from a "buy" rating to a "neutral" rating and cut their target price for the company from $85.00 to $60.00 in a research report on Thursday, May 2nd. Mizuho dropped their price target on shares of CVS Health from $86.00 to $72.00 and set a "buy" rating on the stock in a research note on Thursday, May 2nd. TD Cowen lowered CVS Health from a "buy" rating to a "hold" rating and reduced their price objective for the stock from $99.00 to $59.00 in a research note on Tuesday, May 7th. Finally, Leerink Partnrs downgraded CVS Health from an "outperform" rating to a "market perform" rating in a research report on Wednesday, May 1st. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $76.75.

CVS Health Stock Down 0.1 %

The company has a market capitalization of $71.96 billion, a PE ratio of 10.07, a PEG ratio of 0.55 and a beta of 0.56. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. The company's 50 day moving average is $68.33 and its two-hundred day moving average is $72.24.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same period last year, the firm posted $2.20 earnings per share. The company's revenue for the quarter was up 3.7% compared to the same quarter last year. On average, analysts anticipate that CVS Health Co. will post 7.02 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Friday, April 19th. This represents a $2.66 annualized dividend and a yield of 4.64%. CVS Health's payout ratio is currently 46.75%.

Insider Buying and Selling

In other CVS Health news, Director Edward J. Ludwig bought 1,000 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were purchased at an average price of $53.88 per share, with a total value of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at approximately $1,165,424.40. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.24% of the stock is owned by corporate insiders.

Institutional Trading of CVS Health

Large investors have recently made changes to their positions in the stock. Bryn Mawr Capital Management LLC increased its position in shares of CVS Health by 74.0% during the third quarter. Bryn Mawr Capital Management LLC now owns 43,213 shares of the pharmacy operator's stock worth $3,017,000 after acquiring an additional 18,385 shares during the period. Checchi Capital Advisers LLC raised its position in CVS Health by 2.3% during the 3rd quarter. Checchi Capital Advisers LLC now owns 10,405 shares of the pharmacy operator's stock valued at $726,000 after purchasing an additional 233 shares in the last quarter. Personal CFO Solutions LLC lifted its holdings in shares of CVS Health by 2.6% in the 3rd quarter. Personal CFO Solutions LLC now owns 19,355 shares of the pharmacy operator's stock worth $1,351,000 after buying an additional 491 shares during the period. Riverpoint Wealth Management Holdings LLC purchased a new position in shares of CVS Health during the fourth quarter valued at $218,000. Finally, Canoe Financial LP lifted its stake in CVS Health by 95.1% in the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator's stock worth $139,177,000 after acquiring an additional 859,134 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.